Related Experiment Video
Updated: Mar 7, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Re-evaluating the Incidence of Idiopathic Intracranial Hypertension in an Era of Increasing Obesity
Khin P Kilgore1, Michael S Lee2, Jacqueline A Leavitt3
1College of Medicine, Mayo Clinic, Jacksonville, Florida; Department of Ophthalmology, Mayo Clinic, Jacksonville, Florida.
Purpose:
To re-evaluate the population-based incidence of idiopathic intracranial hypertension (IIH) and to determine if it mirrors the rise in obesity.
Design:
Retrospective, population-based cohort.
Participants:
All residents of Olmsted County, Minnesota, diagnosed with IIH between January 1, 1990, and December 31, 2014.
Methods:
All cases of IIH were identified using the Rochester Epidemiology Project, which is a record-linkage system of medical records for all patient-physician encounters among Olmsted County, Minnesota, residents. All medical records were reviewed to confirm a diagnosis of IIH. The incidence rates of IIH were compared against the incidence of obesity in Minnesota over the same period.
Main Outcome Measures:
Incidence of IIH, lumbar puncture opening pressures, and body mass index.
Results:
There were 63 new cases of IIH, yielding an overall age- and gender-adjusted annual incidence of 1.8 per 100 000 (95% confidence interval, 1.3-2.2) between 1990 and 2014. It increased from 1.0 per 100 000 (1990-2001) to 2.4 per 100 000 (2002-2014; P = 0.007). The incidence of IIH was 3.3 per 100 000 in women and 0.3 per 100 000 in men (P ≤ 0.001). In obese women 15 to 44 years of age, the incidence was 22.0 per 100 000 compared with 6.8 per 100 000 among all women in the same age group. A strong correlation was observed between IIH incidence rates and obesity rates in Minnesota (R2 = 0.70, P = 0.008).
Conclusions:
The incidence of IIH has increased since 1990, which is highly correlated with the rise in obesity during the same period.
More Related Videos
Related Concept Videos
Drug Dosing: Obese Patients
Glaucoma: Overview
Obesity
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

